We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
Cap. Flow
+$188M
Cap. Flow %
3.27%
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$136M
2
FRPT icon
Freshpet
FRPT
+$91.3M
3
ROST icon
Ross Stores
ROST
+$81.3M
4
FIVE icon
Five Below
FIVE
+$72.6M
5
EXAS
Exact Sciences
EXAS
+$64.3M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$75.6M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$71.5M
3
ILMN icon
Illumina
ILMN
+$62.5M
4
AZN icon
AstraZeneca
AZN
+$55.2M
5
TSCO icon
Tractor Supply
TSCO
+$51.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.48%
2 Miscellaneous 31.17%
3 Consumer Discretionary 9.47%
4 Consumer Staples 8.21%
5 Technology 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAYC icon
226
Paycom
PAYC
$9.91B
– –
-20,000
Closed -$5.6M
REAL icon
227
The RealReal
REAL
$1.19B
– –
-300,000
Closed -$747K
EZRA
228
Reliance Global Group
EZRA
$2.31M
– –
-131
Closed -$2.82M
HIND
229
Vyome Holdings
HIND
$15.2M
– –
0
– -$82K
SAM icon
230
Boston Beer
SAM
$1.66B
– –
-32,000
Closed -$9.7M
SPRC icon
231
SciSparc
SPRC
$3.02M
– –
-68
Closed -$714K
SPY icon
232
State Street SPDR S&P 500 ETF Trust
SPY
$810B
– –
-33,500
Closed -$13.3M
TOPS icon
233
TOP Ships
TOPS
$4.03M
– –
-7,637
Closed -$695K
TSCO icon
234
Tractor Supply
TSCO
$18.3B
– –
-1,336,125
Closed -$51.8M
ULTA icon
235
Ulta Beauty
ULTA
$23.6B
– –
-66,431
Closed -$25.6M
VRME icon
236
VerifyMe
VRME
$7.85M
– –
-786,896
Closed -$1.54M
VTRS icon
237
Viatris
VTRS
$19.1B
– –
-500,000
Closed -$5.24M
WMT icon
238
Walmart Inc
WMT
$843B
– –
-1,052,574
Closed -$42.7M
WYNN icon
239
Wynn Resorts
WYNN
$9.52B
– –
-172,000
Closed -$9.8M
YUM icon
240
Yum! Brands
YUM
$40.7B
– –
-151,713
Closed -$17.2M
EGRX
241
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-150,000
Closed -$6.67M
ARAV
242
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-1,316,129
Closed -$1.3M
AVTA
243
DELISTED
Avantax, Inc. Common Stock
AVTA
– –
-736,000
Closed -$13.6M
MKUL
244
DELISTED
Molekule Group, Inc. Common Stock
MKUL
– –
-1,500,000
Closed -$19.6M
AJRD
245
DELISTED
Aerojet Rocketdyne Holdings
AJRD
– –
-560,000
Closed -$22.7M
OG
246
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
– –
-943,390
Closed -$830K
FMTX
247
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-4,736,000
Closed -$32.6M
PTE
248
DELISTED
PolarityTE, Inc. Common Stock
PTE
– –
-140,163
Closed -$203K
6 7 8 9
10

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.

  • Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
  • Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
  • Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
  • Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
  • Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
  • Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.

Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.